Back
Aclaris Therapeutics Vs. PTC Therapeutics Industry Stock Comparison
Sell
19
ACRS
Aclaris Therapeutics
Last Price:
1.16
Seasonality Move:
-0.39%
Buy
75
PTCT
PTC Therapeutics
Last Price:
38.65
Seasonality Move:
18.02%
Sell
19
Aclaris Therapeutics (ACRS)
is a Sell
Is Aclaris Therapeutics a Buy, Sell or Hold?
- The current Aclaris Therapeutics [ACRS] share price is $1.19. The Score for ACRS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- ACRS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
75
PTC Therapeutics (PTCT)
is a Buy
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $40.12. The Score for PTCT is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- PTCT is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ACRS Stock Price Chart
What is Aclaris Therapeutics's stock price today?
-
The Aclaris Therapeutics share price today is $1.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACRS is experiencing slight buying pressure.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $40.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing buying pressure, which is a positive indicator for future bullish movement.
ACRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 45.5 | Sell |
| Chaikin Money Flow: | 101972 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.18 - 1.28) | Sell |
| Bollinger Bands (100): | (1.12 - 1.28) | Sell |
PTCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.88 | Buy |
| Relative Strength Index (14 RSI): | 75.48 | Buy |
| Chaikin Money Flow: | 1813835 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.43 - 34.31) | Buy |
| Bollinger Bands (100): | (25.83 - 31.27) | Buy |
ACRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.19 | Buy |
| 20-day SMA: | 1.23 | Sell |
| 50-day SMA: | 1.22 | Sell |
| 200-day SMA: | 3.05 | Sell |
| 8-day EMA: | 1.2 | Sell |
| 20-day EMA: | 1.22 | Sell |
| 50-day EMA: | 1.24 | Sell |
| 200-day EMA: | 3.27 | Sell |
PTCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.39 | Buy |
| 20-day SMA: | 31.64 | Buy |
| 50-day SMA: | 29.52 | Buy |
| 200-day SMA: | 28.16 | Buy |
| 8-day EMA: | 34.27 | Buy |
| 20-day EMA: | 32.1 | Buy |
| 50-day EMA: | 30.09 | Buy |
| 200-day EMA: | 30.46 | Buy |
Aclaris Therapeutics Earnings Growth & ACRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.32 per share, an increase next quarter of $0.04 per share, an increase this year of $0.86 per share, and an increase next year of $0.23 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.31 per share, a decrease this year of $0.10 per share, and an increase next year of $2.67 per share.
Aclaris Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
PTC Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||